Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

99.39 -0.72 (-0.72%)
Streaming Delayed Price Updated: 1:18 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
Microfluidics Market Worth $58.8 Billion by 2026 - Exclusive Report by MarketsandMarkets™
Microfluidics Market categorizes the global market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics),... 
Via SBWire
Illumina's Sustainability Efforts Rewarded With Gold Rating From EcoVadis
SOURCE: Illumina 
Via 3BL Media
Bioinformatics Market Worth $21.8 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The global bioinformatics market is projected to reach $21.8 billion by 2026. Bioinformatics platforms market report provides crucial industry insights that will help your business grow. 
Via SBWire
Illumina Ventures Closes $325 Million Fund Supporting Start-ups in Healthcare Innovation
SOURCE: Illumina 
Via 3BL Media
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
Some trends will persist for decades. 
Via The Motley Fool
Illumina's Spotlight on Ovarian Cancer: Understanding Tumors Through Comprehensive Genomic Profiling
SOURCE: Illumina 
Via 3BL Media
Illumina Celebrates International Equal Pay Day
SOURCE: Illumina 
Via 3BL Media
On World Cancer Research Day, Illumina Highlights the Transformative Power of Genomics
SOURCE: Illumina 
Via 3BL Media
Topics Artificial Intelligence Death
Cancer Diagnostics Market Worth $26.6 Billion by 2026 – Growing Focus on Personalized Medicine and Leading Key Players
The global cancer diagnostics market size is projected to reach USD 26.6 billion by 2026 from USD 17.2 billion in 2021, at a CAGR of 11.5% during the forecast period 
Via SBWire
For the Fourth Consecutive Year, Illumina Was Recognized As a Platinum Tier SANDAG iCommute Diamond Award Winner
SOURCE: Illumina 
Via 3BL Media
Topics Emissions
Illumina Begins Climate Week by Highlighting How Sequencing Supports Resilient Responses to Climate Change
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change Death
Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle
SOURCE: Illumina 
Via 3BL Media
Next-generation Sequencing (NGS) Market worth $24.2 billion by 2026 | Key Players are Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US)
Via AB Newswire
UK's NHS Launches World's Largest Trial Of Blood Test For 50 Types
Britain's National Health Service (NHS) will begin the world's largest trial of Grail Inc's flagship Galleri blood test that can be used to detect... 
Via Benzinga
Single-Cell Analysis Market Worth $6.3 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The global single-cell analysis market is projected to reach $6.3 billion by 2026. Single cell data analysis market report provides crucial industry insights that will help your business grow. 
Via SBWire
Illumina Named #1 for Workers in Its Industry by JUST Capital
SOURCE: Illumina 
Via 3BL Media
Genomics Market worth $54.4 billion by 2025 | Key Players are Illumina, Inc. (US),Thermo Fisher Scientific (US) QIAGEN N.V. (Netherlands)
Via AB Newswire
Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change Emissions
Illumina, Inc. (NASDAQ:ILMN) Investor Alert: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 09/08/2021 -- Illumina, Inc is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay
Illumina Inc (NASDAQ: ILMN) and Merck & Co Inc (NYSE: MRK) provided more details on their partnership to develop and commercialize tests that gauge... 
Via Benzinga
Why Illumina Wants Grail Back So Badly
The gene-sequencing giant sees a huge opportunity in diagnostics. 
Via The Motley Fool
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing. 
Via InvestorPlace
Agrigenomics Market Emerging Trends and Recent Developments
Northbrook, IL -- (SBWIRE) -- 09/02/2021 -- Agrigenomics Market by Application (Crops and Livestock), Sequencer Type (Sanger Sequencing, Illumina HiSeq Family, PacBio Sequencer, SOLiD Sequencer),... 
Via SBWire
Illumina Genomic Discoveries Program Brings Sophisticated Lab Experiences to High School Classrooms
SOURCE: Illumina 
Via 3BL Media
Berry Oncology Utilizes Illumina Technology to Accelerate Early Liver Cancer Detection in China
SOURCE: Illumina 
Via 3BL Media
Workday And Lam Research Lead The QQQ
U.S. indices were trading higher Friday as investors eye Fed Chairman Powell's speech at the Jackson Hole Symposium and gauge Fed tapering policy. The Invesco QQQ Trust... 
Via Benzinga
Topics Economy
Illumina’s Shanghai Family Day Educates Kids on DNA and STEM Activities
SOURCE: Illumina 
Via 3BL Media
Looking into Illumina's Return on Capital Employed
Pulled from Benzinga Pro data Illumina (NASDAQ:ILMN) showed a loss in earnings since Q1, totaling $187.00 million. Sales, on the other hand, increased by 3.02% to $1.13 billion... 
Via Benzinga
Friday Fears and Other Stock News Updates
Toyota has cut its output 40% over fear of the Delta variant of Covid, plus shortages of electronics. This is terrifying markets outside the USA. And other global stock news updates. 
Via Talk Markets
Illumina's Interns Contribute Over 800 Hours on Social Impact Projects
SOURCE: Illumina 
Via 3BL Media
< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.